{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03108677",
      "OrgStudyIdInfo": {
        "OrgStudyId": "RJ2017NO13"
      },
      "Organization": {
        "OrgFullName": "Ruijin Hospital",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma",
      "OfficialTitle": "A Pilot Study of Circulating Exosome RNA as Diagnostic and Prognostic Markers in Lung Metastases of Primary High-Grade Osteosarcoma"
    },
    "StatusModule": {
      "StatusVerifiedDate": "October 2020",
      "OverallStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "May 1, 2017",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "May 2022",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "May 2022",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "April 5, 2017",
      "StudyFirstSubmitQCDate": "April 10, 2017",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "April 11, 2017",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "October 6, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "October 8, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Yuhui Shen",
        "ResponsiblePartyInvestigatorTitle": "Ph.D., M.D.",
        "ResponsiblePartyInvestigatorAffiliation": "Ruijin Hospital"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Ruijin Hospital",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of this study is to learn whether the profile of RNA from circulating exosomes can be used as a biomarker for lung metastases of primary high-grade osteosarcoma. Circulating exosomes plays roles in metastases in many kinds of cancer including osteosarcoma. By RNA profiling researchers may find lung metastases earlier than conventional work-up and predict the oncological outcomes.",
      "DetailedDescription": "Investigators have performed a 4 patients pilot study under the oversight of hospital's ethics committee, and investigator found that the levels and mutations of circulating exosome RNA from patients with or without lung metastasis have significant differences. Then investigators wish to register this study to do a further research, in order to reveal the roles of circulating exosome RNA in metastases of osteosarcoma."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Lung Metastases",
          "Osteosarcoma"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "RNA profiling",
          "Exosome",
          "Lung Metastases",
          "Osteosarcoma"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Observational",
      "PatientRegistry": "Yes",
      "TargetDuration": "3 Years",
      "DesignInfo": {
        "DesignObservationalModelList": {
          "DesignObservationalModel": [
            "Cohort"
          ]
        },
        "DesignTimePerspectiveList": {
          "DesignTimePerspective": [
            "Prospective"
          ]
        }
      },
      "BioSpec": {
        "BioSpecRetention": "Samples Without DNA",
        "BioSpecDescription": "Samples with purified exosome RNA"
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "40",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "metastatic",
            "ArmGroupDescription": "For osteosarcoma patients with metastasis, collecting blood samples.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Blood samples"
              ]
            }
          },
          {
            "ArmGroupLabel": "non-metastatic",
            "ArmGroupDescription": "For osteosarcoma patients without metastasis, collecting blood samples.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Other: Blood samples"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Other",
            "InterventionName": "Blood samples",
            "InterventionDescription": "15 ml peripheral blood",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "metastatic",
                "non-metastatic"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Differences in the levels and mutations of circulating exosome RNA from patients with or without lung metastasis.",
            "PrimaryOutcomeDescription": "Next generation sequencing will be performed to the whole RNA sequencing.",
            "PrimaryOutcomeTimeFrame": "Before the neo-adjuvant chemotherapy, before the definitive surgery procedure, every 6 months after surgery. up to 3 years."
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Differences in the classic cell signal pathway mutations of circulating exosome RNA from patients with or without lung metastasis.",
            "SecondaryOutcomeDescription": "Next generation sequencing will be performed to the whole RNA sequencing.",
            "SecondaryOutcomeTimeFrame": "Before the neo-adjuvant chemotherapy, before the definitive surgery procedure, every 6 months after surgery. up to 3 years."
          },
          {
            "SecondaryOutcomeMeasure": "Differences in the therapeutic targets mutations of circulating exosome RNA from patients with or without lung metastasis.",
            "SecondaryOutcomeDescription": "Next generation sequencing will be performed to the whole RNA sequencing.",
            "SecondaryOutcomeTimeFrame": "Before the neo-adjuvant chemotherapy, before the definitive surgery procedure, every 6 months after surgery. up to 3 years."
          },
          {
            "SecondaryOutcomeMeasure": "The correlation between circulating exosome RNA mutation levels and 3-year disease-free survival (DFS), progression-free survival (PFS), lung metastases.",
            "SecondaryOutcomeDescription": "Next generation sequencing will be performed to the whole RNA sequencing.",
            "SecondaryOutcomeTimeFrame": "Before the neo-adjuvant chemotherapy, before the definitive surgery procedure, every 6 months after surgery. up to 3 years."
          },
          {
            "SecondaryOutcomeMeasure": "The correlation between specific circulating exosome RNA mutations and 3-year disease-free survival (DFS), progression-free survival (PFS), lung metastases.",
            "SecondaryOutcomeDescription": "Next generation sequencing will be performed to the whole RNA sequencing.",
            "SecondaryOutcomeTimeFrame": "Before the neo-adjuvant chemotherapy, before the definitive surgery procedure, every 6 months after surgery. up to 3 years."
          },
          {
            "SecondaryOutcomeMeasure": "The roles of circulating exosome micro-RNA mutations on regulation of circulating exosome RNA.",
            "SecondaryOutcomeDescription": "Next generation sequencing will be performed to the whole RNA sequencing.",
            "SecondaryOutcomeTimeFrame": "Before the neo-adjuvant chemotherapy, before the definitive surgery procedure, every 6 months after surgery. up to 3 years."
          },
          {
            "SecondaryOutcomeMeasure": "The mutations of circulating exosome RNA from patients without metastasis.",
            "SecondaryOutcomeDescription": "Next generation sequencing will be performed to the whole RNA sequencing.",
            "SecondaryOutcomeTimeFrame": "Before the neo-adjuvant chemotherapy, before the definitive surgery procedure, every 6 months after surgery. up to 3 years."
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nDiagnosis by biopsy: primary high-grade osteosarcoma, including conventional osteosarcoma, telangiectatic osteosarcoma, small cell osteosarcoma, high-grade surface osteosarcoma.\nTumor located in the extremities or pelvis.\nAge 12-60 years.\nNo prior history of cancer and no prior treatment elsewhere.\nNo prior history of chronic diseases including autoimmune disease, chronic infection, etc. which may interfere the level of circulating exosomes.\n\nExclusion Criteria:\n\nInitial misdiagnosis confirmed by specimen of definitive surgery.\nApplying target drugs in the period of treatment which may reduce tumor derived exosomes\nwithdraw from the study for any reason",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "12 Years",
      "MaximumAge": "60 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult"
        ]
      },
      "StudyPopulation": "patients with primary high-grade osteosarcoma aged 12-60.",
      "SamplingMethod": "Non-Probability Sample"
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Yuhui Shen, Ph.D., M.D.",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+8613918209875",
            "CentralContactEMail": "yuhuiss@163.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Yuhui Shen, Ph.D., M.D.",
            "OverallOfficialAffiliation": "Ruijin Hospital",
            "OverallOfficialRole": "Principal Investigator"
          },
          {
            "OverallOfficialName": "Weibin Zhang, Ph.D., M.D.",
            "OverallOfficialAffiliation": "Ruijin Hospital",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Ruijin Hospital Shanghai Jiao Tong University School of medicine",
            "LocationStatus": "Recruiting",
            "LocationCity": "Shanghai",
            "LocationState": "Shanghai",
            "LocationZip": "200025",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Yuhui Shen, Ph.D., M.D.",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+8613918209875",
                  "LocationContactEMail": "yuhuiss@163.com"
                },
                {
                  "LocationContactName": "Yuhui Shen, Ph.D., M.D.",
                  "LocationContactRole": "Principal Investigator"
                },
                {
                  "LocationContactName": "Weibin Zhang, Ph.D., M.D.",
                  "LocationContactRole": "Principal Investigator"
                },
                {
                  "LocationContactName": "Fangzhou He, M.D.",
                  "LocationContactRole": "Sub-Investigator"
                },
                {
                  "LocationContactName": "Qiyuan Bao, Ph.D., M.D.",
                  "LocationContactRole": "Sub-Investigator"
                }
              ]
            }
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "29981024",
            "ReferenceType": "derived",
            "ReferenceCitation": "Bao Q, Gong L, Wang J, Wen J, Shen Y, Zhang W. Extracellular Vesicle RNA Sequencing Reveals Dramatic Transcriptomic Alterations Between Metastatic and Primary Osteosarcoma in a Liquid Biopsy Approach. Ann Surg Oncol. 2018 Sep;25(9):2642-2651. doi: 10.1245/s10434-018-6642-z. Epub 2018 Jul 6."
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000009362",
            "ConditionMeshTerm": "Neoplasm Metastasis"
          },
          {
            "ConditionMeshId": "D000016609",
            "ConditionMeshTerm": "Neoplasms, Second Primary"
          },
          {
            "ConditionMeshId": "D000012516",
            "ConditionMeshTerm": "Osteosarcoma"
          },
          {
            "ConditionMeshId": "D000008175",
            "ConditionMeshTerm": "Lung Neoplasms"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000009385",
            "ConditionAncestorTerm": "Neoplastic Processes"
          },
          {
            "ConditionAncestorId": "D000009369",
            "ConditionAncestorTerm": "Neoplasms"
          },
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          },
          {
            "ConditionAncestorId": "D000018213",
            "ConditionAncestorTerm": "Neoplasms, Bone Tissue"
          },
          {
            "ConditionAncestorId": "D000009372",
            "ConditionAncestorTerm": "Neoplasms, Connective Tissue"
          },
          {
            "ConditionAncestorId": "D000018204",
            "ConditionAncestorTerm": "Neoplasms, Connective and Soft Tissue"
          },
          {
            "ConditionAncestorId": "D000009370",
            "ConditionAncestorTerm": "Neoplasms by Histologic Type"
          },
          {
            "ConditionAncestorId": "D000012509",
            "ConditionAncestorTerm": "Sarcoma"
          },
          {
            "ConditionAncestorId": "D000012142",
            "ConditionAncestorTerm": "Respiratory Tract Neoplasms"
          },
          {
            "ConditionAncestorId": "D000013899",
            "ConditionAncestorTerm": "Thoracic Neoplasms"
          },
          {
            "ConditionAncestorId": "D000009371",
            "ConditionAncestorTerm": "Neoplasms by Site"
          },
          {
            "ConditionAncestorId": "D000008171",
            "ConditionAncestorTerm": "Lung Diseases"
          },
          {
            "ConditionAncestorId": "D000012140",
            "ConditionAncestorTerm": "Respiratory Tract Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M11459",
            "ConditionBrowseLeafName": "Neoplasm Metastasis",
            "ConditionBrowseLeafAsFound": "Metastases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M14486",
            "ConditionBrowseLeafName": "Osteosarcoma",
            "ConditionBrowseLeafAsFound": "Osteosarcoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M18141",
            "ConditionBrowseLeafName": "Neoplasms, Second Primary",
            "ConditionBrowseLeafAsFound": "Metastases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M10324",
            "ConditionBrowseLeafName": "Lung Neoplasms",
            "ConditionBrowseLeafAsFound": "Lung Metastases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11482",
            "ConditionBrowseLeafName": "Neoplastic Processes",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M19511",
            "ConditionBrowseLeafName": "Neoplasms, Bone Tissue",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11469",
            "ConditionBrowseLeafName": "Neoplasms, Connective Tissue",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M19502",
            "ConditionBrowseLeafName": "Neoplasms, Connective and Soft Tissue",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11467",
            "ConditionBrowseLeafName": "Neoplasms by Histologic Type",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14479",
            "ConditionBrowseLeafName": "Sarcoma",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14131",
            "ConditionBrowseLeafName": "Respiratory Tract Neoplasms",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M15810",
            "ConditionBrowseLeafName": "Thoracic Neoplasms",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10320",
            "ConditionBrowseLeafName": "Lung Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14129",
            "ConditionBrowseLeafName": "Respiratory Tract Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T4340",
            "ConditionBrowseLeafName": "Osteosarcoma",
            "ConditionBrowseLeafAsFound": "Osteosarcoma",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "T5284",
            "ConditionBrowseLeafName": "Soft Tissue Sarcoma",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC04",
            "ConditionBrowseBranchName": "Neoplasms"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC08",
            "ConditionBrowseBranchName": "Respiratory Tract (Lung and Bronchial) Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}